ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.77
-1.09%
US Tech 100
20,778.00
-0.69%
S&P 500
6,040.53
-0.50%
US Dollar vs CAD
1.45415
0.01%
Bitcoin
99,698.26
-0.97%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immuron Ltd (IMRN)

  7. Immuron Ltd (IMRN) News

IMRN

Immuron (IMRN)

Immuron Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMRN
DateTimeSourceHeadlineSymbolCompany
01/17/20257:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
01/17/20255:00AMGlobeNewswire Inc.Immuron Travelan® continued strong sales growthNASDAQ:IMRNImmuron Ltd
01/15/20257:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
01/15/20255:00AMGlobeNewswire Inc.Immuron Announces New Research Collaboration targeting Antimicrobial ResistanceNASDAQ:IMRNImmuron Ltd
01/14/20257:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
01/14/20255:00AMGlobeNewswire Inc.Immuron Announces Travelan® Clinical Trial UpdateNASDAQ:IMRNImmuron Ltd
01/10/20256:26AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
01/08/20256:48AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
12/10/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
12/06/20248:17AMGlobeNewswire Inc.UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online ViewingNASDAQ:IMRNImmuron Ltd
12/06/20247:35AMGlobeNewswire Inc.Small Cap Growth Virtual Investor Conference Agenda Announced for December 5thNASDAQ:IMRNImmuron Ltd
12/03/20247:35AMGlobeNewswire Inc.Small Cap Growth Virtual Investor Conference Agenda Announced for December 5thNASDAQ:IMRNImmuron Ltd
12/02/20245:00AMGlobeNewswire Inc.Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5thNASDAQ:IMRNImmuron Ltd
11/22/20245:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
11/21/20245:33PMGlobeNewswire Inc.Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventNASDAQ:IMRNImmuron Ltd
11/18/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
11/14/20245:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
10/29/20245:22AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
10/18/20245:06AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
10/16/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
10/16/20245:00AMGlobeNewswire Inc.Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare ConferenceNASDAQ:IMRNImmuron Ltd
10/15/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
10/15/20245:00AMGlobeNewswire Inc.Immuron Travelan® continued strong sales growthNASDAQ:IMRNImmuron Ltd
10/08/20246:19AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
10/04/20245:30AMGlobeNewswire Inc.NMRC Reports Results for Campylobacter Controlled Human Infection Model StudyNASDAQ:IMRNImmuron Ltd
10/04/20245:20AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
10/01/20247:00AMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:IMRNImmuron Ltd
09/26/20246:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
09/09/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
09/05/202410:54AMGlobeNewswire Inc.Immuron Plans Phase 2 Trial for IMM-529 following FDA reviewNASDAQ:IMRNImmuron Ltd
 Showing the most relevant articles for your search:NASDAQ:IMRN

Your Recent History

USOTC
NWBO
Northwest Biotherapeutics (QB)
COIN
XRPUSD
Ripple
COIN
BTCUSD
Bitcoin
USOTC
BIEL
Bioelectronics (PK)
USOTC
LEHNQ
Lehman Brothers Financial (CE)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
COOP
Mr Cooper
NASDAQ
AMRN
Amarin
USOTC
NBRI
North Bay Resources (PK)
USOTC
FNMA
Fannie Mae (QB)
NASDAQ
NVDA
NVIDIA
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
HMBL
HUMBL (PK)
NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads